SCHEMBL15475162

SCHEMBL15475162

Oc1c[c]c(N2CCCCC2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.37
HPGD P15428 5/20 0.37
KMT2A Q03164 5/20 0.37
MAPT P10636 3/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
ADORA3 P0DMS8 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA2B P29275 1/20 0.33
ADORA1 P30542 1/20 0.33
MEN1 O00255 4/20 0.33
ACHE P22303 1/20 0.33
PIM1 P11309 1/20 0.32
TSHR P16473 1/20 0.32
GFER P55789 1/20 0.32
ALOX15 P16050 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
TDP1 Q9NUW8 1/20 0.32
NPC1 O15118 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15475005 0.98 ALDH1A1 (0.34) ALDH1A1HPGDKMT2AMAPTCYP1A2
SCHEMBL15474616 0.83 CHRNB2 (0.44) KMT2AMEN1TDP1
SCHEMBL15474770 0.81 DRD2 (0.37) ALDH1A1KMT2AMAPTADORA1GFER
SCHEMBL15475163 0.81 AR (0.39) ALDH1A1HPGDKMT2AMAPTCYP1A2
SCHEMBL15475104 0.78 GAA (0.45) ALDH1A1KMT2AMAPTMEN1TSHR
SCHEMBL6258105 0.76 ALDH1A1 (0.48) ALDH1A1KMT2AMAPTMEN1ACHE
SCHEMBL357980 0.76 ALDH1A1 (0.42) ALDH1A1HPGDKMT2AMAPTCYP1A2
SCHEMBL358738 0.76 ALDH1A1 (0.42) ALDH1A1HPGDKMT2AMAPTCYP1A2
SCHEMBL15474699 0.76 DRD4 (0.57) ALDH1A1GAA
SCHEMBL357815 0.76 HRH3 (0.41) ALDH1A1CYP2C19ACHEPOLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021006267-A1 SALT OF PYRAZOLE DERIVATIVE AND PREPARATION OF PYRAZOLE DERIVATIVE グリーン・テック株式会社 2021-01-14 WO disclosed
WO-2020235582-A1 PREVENTIVE AND/OR THERAPEUTIC AGENT FOR MOTOR NEURON DISEASE グリーン・テック株式会社 (JP) 2020-11-26 WO disclosed
EP-3323816-A1 NOVEL PYRAZOLE DERIVATIVE Green Tech Co., Ltd. (JP) 2018-05-23 EP disclosed
US-9399635-B2 Pyrazole derivative GREEN TECH CO., LTD. (JP) 2016-07-26 US disclosed
US-20140088029-A1 NOVEL PYRAZOLE DERIVATIVE PHARMA EIGHT CO., LTD. (JP) 2014-03-27 US disclosed
EP-2698368-A1 NOVEL PYRAZOLE DERIVATIVE Pharma Eight Co. Ltd (JP) 2014-02-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140088029-A1 NOVEL PYRAZOLE DERIVATIVE PSEN2, MAPT, PSEN1 ALDH1A1 675/4885HPGD 2351/4885KMT2A 2085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.